WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies, including diabetic peripheral neuropathy, announced today that it has signed an exclusive licensing agreement with EyeTel Imaging, Inc. The agreement grants NeuroMetrix an Exclusive License to market, brand, and sell EyeTel’s DigiScope® throughout the physician office arena. The DigiScope, developed in collaboration with the Wilmer Eye Institute at Johns Hopkins, is a FDA-cleared diagnostic device that primary diabetes care physicians (Primary Care, Family Practice, Internal Medicine and Endocrinology) can use for the early detection of diabetic retinopathy.
